Form 4: Organogenesis Holdings Inc. Executive Reports Stock Transaction
SEC Form 4
Robert Cavorsi, Vice President of Strategy at Organogenesis Holdings Inc., reports disposition of shares to cover tax obligations.
Summary
- On July 16, 2024, Robert Cavorsi, Vice President of Strategy at Organogenesis Holdings Inc., reported a transaction involving Class A Common Stock.
- Cavorsi disposed of 317 shares at a price of $3.09 per share to cover tax obligations.
- Following the transaction, Cavorsi directly owns 139,766 shares of Organogenesis Holdings Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a stock transaction, which is neutral in sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of company executives.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership by a company executive.
Key Dates
| Date | Description |
|---|---|
| 07/16/2024 | Date of stock transaction |
| 07/18/2024 | Date of signature on the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.